Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Bortezomib |
| Trade Name | Velcade |
| Synonyms | |
| Drug Descriptions |
Velcade (bortezomib) is a reversible proteasome inhibitor that inhibits survival of malignant cells and regulates bone remodeling (PMID: 26579531). Velcade (bortezomib) is FDA approved for the treatment of mantle cell lymphoma and multiple myeloma (FDA.gov). |
| DrugClasses | |
| CAS Registry Number | 179324-69-7 |
| NCIT ID | C1851 |